ecrin-mdr-crcClinical2005Use for the treatment of advanced/metastatic colorectal cancer, as third/fourth line chemioterapy.Use For The Treatment Of Advanced/metastatic Colorectal Cancer, As Third/fourth Line Chemioterapy.Interventionalhttps://newmdr.ecrin.org/Study/2518268Italy12BrostallicinECRIN MDRCompletedfalsePhase II exploratory study of brostallicin PNU-166196A as third/fourth line chemoterapy in adult patients with advanced/metastatic colorectal cancer CRC .2005-12-1525182682005-004200-36